http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2006335138-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4add7e8af694d8c07c2659fe21e093c5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D489-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D489-12
filingDate 2006-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ab954c565edf677e917d82c6de75f15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5526e4747a9dcfa41dba958c6774fec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f13446caa0a4af4492fe624727fff17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f61c6da21100bd64109f1879f9a0b4e6
publicationDate 2012-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2006335138-B2
titleOfInvention The use of oripavine as a starting material for buprenorphine
abstract There is provided a method for the synthesis of norbuprenorphine, and ultimately buprenorphine, utilizing oripavine as the starting material. Conventional methods of producing buprenorphine utilize thebaine as the starting material, requiring an O-demethylation step, typically a low to moderate yield transformation. The present use of oripavine as a starting material does not require an O-demethylation step, since the oripavine molecule lacks an O-3 methyl group.
priorityDate 2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1439179-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10430
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415773084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458399598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415721667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416004686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408978443
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426326933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545923
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID547836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5324289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452953813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408671671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35945

Total number of triples: 50.